Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues

Endokrynologia Polska

Volumn 67, Issue 1, 2016, Pages 68-71

  Kunikowska, Jolanta ^a   Ziemnicka, Katarzyna ^b   Pawlak, Dariusz ^c   Ruchała, Marek ^b   Kolasa, Anna ^a   Janicka Jedyńska, Małgorzata ^b   Woźniak, Aldona ^b   Mikołajczak, Renata ^c   Królicki, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c NATIONAL CENTRE FOR NUCLEAR RESEARCH   (Poland)

Author keywords

68Ga; CCK2 receptor; Medullary thyroid carcinoma; PET CT; Somatostatin receptor

Indexed keywords

CALCITONIN; CD56 ANTIGEN; CHOLECYSTOKININ B RECEPTOR; DOTATATE GA 68; GASTRIN GA 68; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG; DOTATATE GALLIUM GA-68; GASTRIN; ORGANOMETALLIC COMPOUND; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR SUBTYPE 2, HUMAN;

AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR BIOPSY; ANALOGS AND DERIVATIVES; CARCINOMA, NEUROENDOCRINE; CHEMISTRY; DIAGNOSTIC IMAGING; METABOLISM; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; THYROID NEOPLASMS;

AGED; CARCINOMA, NEUROENDOCRINE; GASTRINS; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84959917040     PISSN: 0423104X     EISSN: 22998306     Source Type: Journal    
DOI: 10.5603/EP.2016.0010     Document Type: Article

References (18)

1. Smailov SI, Piulatova NR. Postoperative calcitonin study in medullary thyroid carcinoma. Endocr Relat Cancer 2004; 11: 357-363.
2. Rufini V, Salvatori M, Garganese MC et al. Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma. Rays 2000; 25: 273-282.
3. Kloos RT, Eng C, Evans DB et al. American Thyroid Association Guidelines Task Force Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612.
4. Gotthardt M, Béhé MP, Beuter D et al. Improved tumour detection by gastrin receptor scintigraphy in patients with metastasized medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2006; 33: 1273-1279.
5. Kosowicz J, Mikołajczak R, Czepczyński R et al. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc- EDDA/ /HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Canc Biother Radiopharm 2007; 22: 613-628.
6. De Herder WW, Hofland LJ, van der Lely AJ et al. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. Endocrine-Related Cancer 2003; 10: 451-458.
7. Tisell LE, Ahlman H, Wangberg B et al. Somatostatin receptor scintigraphy in medullary thyroid carcinoma. Br J Surg 1997; 84: 543-547.
8. Kaltsas G, Rockall A, Papadogias D et al. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 2004; 151: 15-27.
9. Lodish M, Dagalkis U, Chen CC et al. 111In-Octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab 2012; 97: E207-E212.
10. Kloos RT, Eng C, Evans DB et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612.
11. Dahlberg J, Bumming P, Gjertsson P et al. Routine preoperative (111) In-octreotide scintigraphy in patients with medullary thyroid cancer. Langenbecks Arch Surg 2013; 398: 875-880.
12. Blaker M, de Weerth A, Tometten M et al. Expression of the cholecystokinin2- receptor in normal human thyroid gland and medullary thyroid carcinoma. Eur J Endocrinol 2002; 146: 89-96.
13. Gier B, Butler PC, Lai CK et al. Glucagon like peptide-1 receptor expression in the human thyroid gland. J Clin Endocrinol Metab 2012; 97: 121-131.
14. Freichel M, Zink-Lorenz A, Holloschi A et al. Expression of a calciumsensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 1996; 137: 3842-3848.
15. Gotthardt M, Béhé MP, Grass J et al. Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours. Endocrine- Related Cancer 2006; 13: 1203-1211.
16. Slavikova K, Montravers F, Treglia G et al. What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma? Curr Radiopharm 2013; 6: 96-105.
17. Łapińska G, Bryszewska M, Fijołek-Warszewska A et al. The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours. Nucl Med Rev Cent East Eur 2011; 14: 16-20.
18. Treglia G, Castaldi P, Villani MF et al. Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2012; 39: 569-580.